Skip to main content

Table 1 Baseline characteristics of the participant patients

From: Association of left ventricular abnormalities with incident cerebrovascular events and sources of thromboembolism in patients with chronic Chagas cardiomyopathy

Demographics and clinical data

 Total amount of participants

113

 Female

58 (51%)

 Age (years)

56 [45–67]

 BMI (Kg/m2)

26.4 ± 4.6

 NYHA functional class

  I

90 (80%)

  II

15 (13%)

  III

8 (7%)

 Hypertension

43 (38%)

 Diabetes mellitus

5 (4%)

 Dyslipidemia

27 (24%)

 Smokinga

  Never

72 (64%)

  Former

26 (23%)

  Current

10 (9%)

 Medications

  ACE inhibitors or ARBs

64 (57%)

  Beta-blockers

41 (36%)

  Spironolactone

16 (14%)

  Furosemide

26 (23%)

  Thiazides

21 (19%)

  Amiodarone

21 (19%)

  Statins

23 (20%)

  Aspirin

21 (19%)

Electrocardiography

 1st or 2nd degree AV block

30 (27%)

 Left bundle branch block

9 (8%)

 Right bundle branch block

57 (50%)

 Left anterior fascicular block

42 (37%)

 Premature ventricular contractions

17 (15%)

 Low QRS voltage

13 (12%)

  1. ACE angiotensin-converting enzyme, ARB angiotensin receptor blockers, AV atrioventricular, BMI body mass index, NYHA New York Heart Association
  2. aSmoking: five missing data